Etelcalcetide (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Etelcalcetide" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2^nd place

2^nd place

68^th place

117^th place

low place

low place

1centerwatch.com

low place

low place

1semanticscholar.org

11^th place

8^th place

1web.archive.org

1^st place

1^st place

1chemspider.com

8,573^rd place

low place

447^th place

338^th place

amgen.com

amgen.com

"Amgen Submits New Drug Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416)"

investors.amgen.com

"Amgen - Investors - Press Release". investors.amgen.com. Retrieved 30 October 2017.

centerwatch.com

"Parsabiv New FDA Drug Approval | CenterWatch". www.centerwatch.com. Retrieved 30 October 2017.

chemspider.com

"Etelcalcetide". ChemSpider. Retrieved 7 January 2016.

doi.org

Martin KJ, Bell G, Pickthorn K, Huang S, Vick A, Hodsman P, et al. (February 2014). "Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects". Nephrology, Dialysis, Transplantation. 29 (2): 385–92. doi:10.1093/ndt/gft417. PMC 3910343. PMID 24235081.
Blair HA (December 2016). "Etelcalcetide: First Global Approval". Drugs. 76 (18): 1787–1792. doi:10.1007/s40265-016-0671-3. PMID 27900648. S2CID 45000617.
Wu Q, Lai X, Zhu Z, Hong Z, Dong X, Wang T, et al. (August 2015). "Evidence for Chronic Kidney Disease-Mineral and Bone Disorder Associated With Metabolic Pathway Changes". Medicine. 94 (32): e1273. doi:10.1097/MD.0000000000001273. PMC 4616673. PMID 26266360.

europa.eu

ema.europa.eu

"Parsabiv EPAR". European Medicines Agency. 11 November 2016. Retrieved 13 June 2024.
"Parsabiv: EPAR – Product Information" (PDF). European Medicines Agency. 24 November 2016. Archived from the original (PDF) on 17 March 2018. Retrieved 7 January 2017.

fda.gov

accessdata.fda.gov

"Parsabiv (etelcalcetide) Injection". www.accessdata.fda.gov. Retrieved 30 October 2017.

nih.gov

pubmed.ncbi.nlm.nih.gov

Martin KJ, Bell G, Pickthorn K, Huang S, Vick A, Hodsman P, et al. (February 2014). "Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects". Nephrology, Dialysis, Transplantation. 29 (2): 385–92. doi:10.1093/ndt/gft417. PMC 3910343. PMID 24235081.
Blair HA (December 2016). "Etelcalcetide: First Global Approval". Drugs. 76 (18): 1787–1792. doi:10.1007/s40265-016-0671-3. PMID 27900648. S2CID 45000617.
Wu Q, Lai X, Zhu Z, Hong Z, Dong X, Wang T, et al. (August 2015). "Evidence for Chronic Kidney Disease-Mineral and Bone Disorder Associated With Metabolic Pathway Changes". Medicine. 94 (32): e1273. doi:10.1097/MD.0000000000001273. PMC 4616673. PMID 26266360.
"Drug and Device News". P & T. 42 (4): 223–265. April 2017. PMC 5358678. PMID 28381913.

ncbi.nlm.nih.gov

Martin KJ, Bell G, Pickthorn K, Huang S, Vick A, Hodsman P, et al. (February 2014). "Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects". Nephrology, Dialysis, Transplantation. 29 (2): 385–92. doi:10.1093/ndt/gft417. PMC 3910343. PMID 24235081.
Wu Q, Lai X, Zhu Z, Hong Z, Dong X, Wang T, et al. (August 2015). "Evidence for Chronic Kidney Disease-Mineral and Bone Disorder Associated With Metabolic Pathway Changes". Medicine. 94 (32): e1273. doi:10.1097/MD.0000000000001273. PMC 4616673. PMID 26266360.
"Drug and Device News". P & T. 42 (4): 223–265. April 2017. PMC 5358678. PMID 28381913.

dailymed.nlm.nih.gov

"Parsabiv- etelcalcetide injection, solution". DailyMed. 17 February 2021. Retrieved 13 June 2024.

semanticscholar.org

api.semanticscholar.org

Blair HA (December 2016). "Etelcalcetide: First Global Approval". Drugs. 76 (18): 1787–1792. doi:10.1007/s40265-016-0671-3. PMID 27900648. S2CID 45000617.

web.archive.org

"Parsabiv: EPAR – Product Information" (PDF). European Medicines Agency. 24 November 2016. Archived from the original (PDF) on 17 March 2018. Retrieved 7 January 2017.